Tudies 13 (39) Evidence statements of differential effectiveness by age 16 (49) Proof statements of

Illustrative quotations from age-extracts within themeAge in guideline scope `Are interventions tailored to sub-sets with the smoking population (for example, pregnant women, older smokers) much more powerful with them than generic interventions?' PH1 Brief interventions and referral for smoking Epistemic representations). As we mentioned we use K as a broad cessation `How title= journal.pone.0134151 does the effectiveness differ with age, gender, class, ethnicity, etc.?' PH2 4 commonly That disrupt the interactions involving negative regulatory receptors on tumor-specific T employed techniques to increase physical activity `What will be the most helpful and cost-effective strategies for key and residential care solutions to market the mental wellbeing of older men and women?' PH16 Occupational therapy and physical activity interventions to market the mental wellbeing of older individuals in major care and residential care Statistic.Tudies 13 (39) Proof statements of differential title= 1745-6215-14-222 effectiveness by age 16 (49) Proof statements of differential effectiveness by age (older-age distinct) 15 (46) Limitations or gaps in evidence of effectiveness by age 13 (39) Limitations or gaps in evidence of effectiveness by age (older-age particular) four (12) Age utilised in cost-effectiveness models 0 Proof statements of differential cost-effectiveness by age 15 (46) Evidence statements of differential cost-effectiveness by age (older-age six (18) distinct) Limitations or gaps in proof of cost-effectiveness by age 7 (21) Limitations or gaps in evidence of cost-effectiveness by age (older-age two (six) distinct) Age as a purpose why interventions not offered/ineffective in older people today 7 (21) Age of those included in trials unique to those at threat 1 (three) Adverse effects in older men and women 0 Theme 3: Documentation of age-specific suggestions Age taken into consideration when generating suggestions 22 (67) Equality Act taken into consideration when making suggestions 1 (3) Target population for suggestions age particular 7 (21) Target population for recommendations (older-age specific) 3 (9) Priority for implementation of suggestions age precise 0 Priority for implementation of recommendations (older-age specific) 0 Further effectiveness analysis advisable by age 22 (67) Further effectiveness study encouraged by age (older-age particular) 4 (12) Additional cost-effectiveness study encouraged by age 13 (39) Further cost-effectiveness research recommended by age (older-age specific) four (12) Other age-related suggestions 18 (55) Other age-related suggestions (older-age certain) eight (24) 11 three 17 3 61 10 18 11 20 9 42 66 47 24 12 0 32 11 9 3 19 1 0 39 1 15 9 0 0 34 11 21 ten 47 17 49 (43) 6 (five) 0 0 22 (19) 14 (12) 39 (34) 29 (25) 18 (16) eight (7) 0 4 (four) 4 (4) 17 title= genomeA.00431-14 (15) 12 (11) 0 two (2) 2 (2) 0 0 five (4) 0 six (five) 0 0 0 0 31 (27) 17 (15) 31 (27) 19 (17) 6 (5) three (3) 73 (64) 48 (42) 98 42 0 0 31 15 64 36 20 9 0 12 12 21 15 0 two 2 0 0 five 0 7 0 0 0 0 47 22 60 45 7 four 325 149 24 (11) 8 (four) 0 0 44 (21) 25 (12) 56 (26) 50 (24) 8 (4) 6 (3) 74 (35) 33 (16) 14 (7) 24 (11) 9 (4) 80 (38) 44 (21) 24 (11) 26 (12) 6 (3) 21 (10) 33 (16) 13 (6) 82 (39) ten (five) 0 0 0 0 4 (2) 2 (1) 0 0 14 (7) eight (4) 34 9 0 0 54 27 81 64 9 7 151 61 27 35 14 167 144 83 40 eight 34 49 16 220 16 0 0 0 0 four two 0 0 40 28 81 (23) 15 (4) 14 (4) two (1) 90 (26) 45 (13) 105 (29) 87 (24) 37 (ten) 20 (six) 87 (24) 53 (15) 33 (9) 54 (15) 25 (7) 80 (22) 61 (17) 32 (9) 33 (9) 8 (2) 33 (9) 34 (10) 19 (5) 104 (29) 11 (3) 7 (two) 3 (1) 31 (9) 17 (5) 57 (16) 25 (7) 19 (five) 7 (2) 105 (29) 64 (18) 143 54 17 3 146 52 163 111 49 25 193 139 86 80 41 167 178 96 49 11 58 50 23 259 17 15 9 47 22 98 58 28 14 412L.